1-7 of 7
dapagliflozin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitor Use Associated With Fournier’s Gangrene: A Review of Case Reports and Spontaneous Post-Marketing Cases

Bao Anh Tran, Wendy H. Updike, Krystal Bullers, Erini Serag-Bolos
Journal: Clinical Diabetes
Clin Diabetes 2022;40(1):78–86
https://doi.org/10.2337/cd21-0015
Published: 01 January 2022
View articletitled, Sodium–Glucose Cotransporter 2 Inhibitor Use Associated With Fournier’s Gangrene: A Review of Case Reports and Spontaneous Post-Marketing Cases
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitor Use Associated With Fournier’s Gangrene: A Review of Case Reports and Spontaneous Post-Marketing Cases in another window
Journal Articles

Timely News and Notes for Primary Care Providers from the American Diabetes Association

Max Bingham, PhD
Journal: Clinical Diabetes
Clin Diabetes 2020;38(3):iv–viii
https://doi.org/10.2337/cd20-dp03
Published: 01 July 2020
View articletitled, Timely News and Notes for Primary Care Providers from the American Diabetes Association
Open the PDF for Timely News and Notes for Primary Care Providers from the American Diabetes Association in another window
Journal Articles

Timely News and Notes for Primary Care Providers from the American Diabetes Association

Max Bingham, PhD
Journal: Clinical Diabetes
Clin Diabetes 2020;38(1):4–8
https://doi.org/10.2337/cd20-dp01
Published: 01 January 2020
View articletitled, Timely News and Notes for Primary Care Providers from the American Diabetes Association
Open the PDF for Timely News and Notes for Primary Care Providers from the American Diabetes Association in another window
Journal Articles

Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?

Robert H. Eckel, Azeez Farooki, Robert R. Henry, Gary G. Koch, Lawrence A. Leiter
Journal: Clinical Diabetes
Clin Diabetes 2019;37(4):316–337
https://doi.org/10.2337/cd19-0001
Published: 01 October 2019
View articletitled, Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?
Open the PDF for Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice? in another window
Journal Articles

The Role of the Kidney and Sodium-Glucose Cotransporter-2 Inhibition in Diabetes Management

Virginia Valentine, CNS, BC-ADM, CDE, FAADE
Journal: Clinical Diabetes
Clin Diabetes 2012;30(4):151–155
https://doi.org/10.2337/diaclin.30.4.151
Published: 01 October 2012
View articletitled, The Role of the Kidney and Sodium-Glucose Cotransporter-2 Inhibition in Diabetes Management
Open the PDF for The Role of the Kidney and Sodium-Glucose Cotransporter-2 Inhibition in Diabetes Management in another window
Journal Articles

The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?

Lisa S. Rotenstein, BA, Benjamin M. Kozak, BA, Joseph P. Shivers, BA, Mark Yarchoan, BA, John Close, MBA, Kelly L. Close, MBA
Journal: Clinical Diabetes
Clin Diabetes 2012;30(2):44–53
https://doi.org/10.2337/diaclin.30.2.44
Published: 01 April 2012
View articletitled, The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?
Open the PDF for The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We? in another window
Journal Articles

Apple Trees to Sodium Glucose Co-Transporter Inhibitors: A Review of SGLT2 Inhibition

John R. White, Jr., PA, PharmD
Journal: Clinical Diabetes
Clin Diabetes 2010;28(1):5–10
https://doi.org/10.2337/diaclin.28.1.5
Published: 01 January 2010
View articletitled, Apple Trees to Sodium Glucose Co-Transporter Inhibitors: A Review of SGLT2 Inhibition
Open the PDF for Apple Trees to Sodium Glucose Co-Transporter Inhibitors: A Review of SGLT2 Inhibition in another window